Other Stories

Pfizer/BioNTech to boost COVID-19 vaccine supply to 2 bil. doses by end of 2021 Updated: 2021-01-12 07:10:53 KST

Pfizer and BioNTech aim to boost manufacturing capacity to deliver two billion COVID-19 vaccine doses globally by the end of this year.
This is a whopping 54 percent increase from their initial goal of 1.3 billion doses.
BioNTech explained in a presentation Monday, that the updated label now reflects the availability of six doses from each vial, up from the original five doses, will be able to help increase supply capacity.
It also added operations at its newly acquired production site in western Germany will begin by the end of February , boosting capacity by 750 million doses per year.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.